Abraham Chang
Senior Associate
Norton Rose Fulbright US LLP
Related services and key industries
Biography
Abraham Chang is an associate in the Houston office, where his practice focuses on antitrust and complex commercial litigation. He has counseled clients in the energy, healthcare, insurance, sanitation, and pharmaceutical industries on issues arising from antitrust litigation, merger and acquisition analysis and antitrust compliance.
Professional experience
Collapse allJD, University of Virginia, 2016
BA, Political Science, History, Duke University, 2013
While at University of Virginia Law School, Abraham was an Articles Editor of the Tax Review.
- Texas State Bar
- Counsel defending hospital system in antitrust action alleging merger-based claims under Sherman and Clayton Acts
- Counsel defending pharmaceutical company in litigation over alleged refusal to sell non-patented product to a potential competitor
- Counsel for university foundation in class action where plaintiff alleges breach of contract and other violations
- Counsel for national oil change franchisor in putative antitrust class action where plaintiff alleges employment restrictions in franchise agreements violate Sherman Act
- Advised fintech in responding to civil investigative demand regarding acquisition of financial services company by card network
- Advised pharmaceutical manufacturer in responding to civil investigative demand regarding access to drug for purported generic entry purposes
- Advised national sporting goods retailer in responding to civil investigative demand regarding merger of outdoor/sports equipment retailers
- Advised client regarding potential antitrust issues raised by proposed acquisition in the energy space
- Ones to Watch - Commercial Litigation, Best Lawyers, 2024
- Co-author with Amanda Wait, "US DOJ and FTC issue vertical merger guidelines," Norton Rose Fulbright Legal Update, October 12, 2020
- Co-author, "US antitrust agencies COVID-19 response: Merger reviews," Norton Rose Fulbright Legal Update, March 2020
- Co-author, "FTC and DOJ release 2020 Draft Vertical Merger Guidelines for public comment," Norton Rose Fulbright Legal Update, January 2020
- Co-author, "American Express steers clear of antitrust law violation," Norton Rose Fulbright Legal Update, June 26, 2018
- Co-author, "Vitamin antitrust price fixing litigation update: the effect of a foreign government's interpretation of its own laws is now limited," Norton Rose Fulbright Legal Update, June 20, 2018
- Co-author, "China's role in US antitrust litigation: When should a US court defer to a foreign government's interpretation of its law?" Norton Rose Fulbright Legal Update, February 12, 2018
- "Teleconference Summary: Extra! Extra! Do Newspapers Need an Antitrust Exemption?" ABA E&I Update, Fall 2017
Insights
“Climate cartel” or sustainability?
Publication | February 06, 2023
“Climate cartel” or sustainability?
Publication | January 31, 2023
US FTC proposes ban on non-compete clauses
Publication | January 05, 2023